CAS: 4775-80-8; S-Phenylmercapturic Acid

上下游产品

N-acetylcystein S-(4-Bromophenyl)mercapturic acid (R)-2-acetamido-3-((4-bromophenyl)thio)propanoic acid S-phenyl-L-cysteine2-(S)-amino-3-phenylsulfanylpropionic acid acetic acid (R)-2-Acetylamino-3-benzenesulfinyl-N-benzyl-propionamide

📜N-乙酰-L-半胱氨酸置于buffered Hcl-Salt Benzenediazonium-Chloride-Solution体系中,化学反应生成 S-苯汞基酸
参考文献:Zbarsky; Young,Journal Of Biological Chemistry,1943,Vol. 151,P. 211,212
标题:Zbarsky; Young,Journal Of Biological Chemistry,1943,Vol. 151,P. 211,212

专利信息

专利号:US-2024355410-A1
优先权日:2021-10-27
标题:Method and systems for a machine-assisted discovery of chondroitinase abc complexes towards sustained neural regeneration
发明人：GORMLEY ADAM J; TAMASI MATTHEW; KOSURI SHASHANK; WEBB MICHAEL ANTHONY; BORCA CARLOS HERNAN; PATEL ROSHAN ANIT
权利人:UNIV RUTGERS; UNIV PRINCETON
摘要:Disclosed are systems and methods that provide a framework for machine-assisted discovery of Chondroitinase ABC (ChABC) complexes towards sustained neural regeneration. In some embodiments, the framework may leverage a determination of a diverse set of tailor-made random copolymers that complex and stabilize ChABC at physiological temperature. The copolymer designs, which are based on chain length and/or composition of the copolymers, may be identified using an active machine learning paradigm, which involves, but is not limited to, copolymer synthesis, testing for ChABC thermostability upon copolymer complexation, Gaussian Process Regression modeling and Bayesian optimization. Copolymers are synthesized by automated PET-RAFT, and thermostability of ChABC may be assessed by retained enzyme activity (REA) after a predefined interval of hours at 37° C.

专利号:WO-2022270853-A1
优先权日:2021-06-21
标 题:Clcf1 protein and use thereof
发明人：KWON KI-SUN; YANG YONG RYOUL; PARK JI HOON; CHOI SO-YOUNG; KANG JAE SOOK; KIM MINJU
权利人:KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY; OSONG MEDICAL INNOVATION FOUND
摘要:The present invention relates to a composition for preventing or treating a muscular disease having at least one symptom selected from muscle damage, muscular dysfunction, muscle weakness, muscle atrophy, and muscle mass decline, a composition for promoting differentiation of myoblasts, and a composition for strengthening muscle strength or increasing muscle mass, each comprising CLCF1 protein or a variant thereof as an active ingredient. In one embodiment of the present invention, the CLCF1 protein or a variant thereof has effects of increasing muscle mass, promoting protein synthesis in myocytes, improving muscle functions, and increasing resistance to muscle fatigue, so that the composition according to the present invention can be advantageously used for promoting differentiation of myoblasts and preventing, alleviating, or treating diseases related to muscle loss and/or muscle weakness.